All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @dr.allen.hormones on TikTok · 63s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @dr.allen.hormones's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00But when estrogen's high, progesterone's low and testosterone, that's when girls have no desire for intimacy or first of all,
  2. 0:09the main issue that I've seen over all the time that I've been doing hormones is that
  3. 0:17the first hormone in women to go low, like if they have a child after delivery, after their second is testosterone.
  4. 0:26And so testosterone, which is the hormone that helps girls have energy to lose belly fat that makes collagen in their skin, makes them look young, helps them recover, like all the important things, they lose that.
  5. 0:42And so the next hormone to go low, in my experience, is then progesterone, and then full menopause, which means they don't make any hormones, but then the next one would be estrogen.
  6. 0:52So that's kind of the last one. But when estrogen's high, progesterone's low and testosterone, that's when girls have no desire for intimacy or to go chasing their honey around.

Does low libido in women always come down to hormones?

Dr. Allen

TikTok creator

12.4K viewsWatch on TikTok

Quick answer

Dr. Allen proposes a three-hormone decline sequence in women (testosterone first, then progesterone, then estrogen) and links the specific combination of high estrogen, low progesterone, and low testosterone to absent sexual desire. While low testosterone is associated with reduced libido in some women, the postpartum hormonal environment is primarily characterized by prolactin elevation and sharp estrogen-progesterone withdrawal, not testosterone-first decline. Clinicians evaluating female sexual dysfunction should obtain a full hormonal panel rather than assuming a fixed sequence of deficiency.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Does low libido in women always come down to hormones?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Does low libido in women always come down to hormones? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Does low libido in women always come down to hormones?" from Dr. Allen. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Dr.

The reason this review is not generic is the source wording and the canonical claim label "trt low libido this is one of the first symptoms that comes up c." In this clip, the useful excerpt is: "But when estrogen's high, progesterone's low and testosterone, that's when girls have no desire for intimacy or first of all, the main issue that I've seen over all the time that I've been doing hormones is that the first hormone in women..." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Low testosterone is associated with reduced sexual desire in some women, but the FDA has not approved any testosterone product specifically for female sexual dysfunction in the US as of 2024.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Dr.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Dr. Allen proposes a three-hormone decline sequence in women (testosterone first, then progesterone, then estrogen) and links the specific combination of high estrogen, low progesterone, and low testosterone to absent sexual desire. While low testosterone is associated with reduced libido in some women, the postpartum hormonal environment is primarily characterized by prolactin elevation and sharp estrogen-progesterone withdrawal, not testosterone-first decline. Clinicians evaluating female sexual dysfunction should obtain a full hormonal panel rather than assuming a fixed sequence of deficiency.
  • Postpartum hormone changes are dominated by estrogen and progesterone withdrawal plus prolactin elevation, not a testosterone-first decline; no peer-reviewed consensus supports the sequence Dr. Allen describes.
  • Low testosterone is associated with reduced sexual desire in some women, but the FDA has not approved any testosterone product specifically for female sexual dysfunction in the US as of 2024.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Postpartum hormone changes are dominated by estrogen and progesterone withdrawal plus prolactin elevation, not a testosterone-first decline; no peer-reviewed consensus supports the sequence Dr. Allen describes.
  • Low testosterone is associated with reduced sexual desire in some women, but the FDA has not approved any testosterone product specifically for female sexual dysfunction in the US as of 2024.
  • STRAW+10 (Harlow et al., 2012, Fertility and Sterility) defines perimenopause through rising FSH and erratic estradiol, not a neat three-hormone stepwise decline.
  • A proper hormonal workup for low libido in women should include free and total testosterone, estradiol, progesterone (cycle-timed if premenopausal), FSH, LH, prolactin, and thyroid function, not a predetermined diagnosis.
  • Braunstein et al. (2005, NEJM) found that transdermal testosterone improved sexual function in surgically menopausal women, giving some legitimacy to testosterone's role, though this does not confirm Dr. Allen's specific decline sequence.
  • Female sexual dysfunction is multifactorial; Davis and Worsley (2014, Journal of Sexual Medicine) noted that hormones, mental health, relationship quality, and medications all contribute and should be assessed together.
  • Providers offering hormone therapy should base treatment on individual lab values and symptoms, not a clinical narrative about universal hormonal decline order.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @dr.allen.hormones actually say?

Dr. Allen laid out a specific hormonal decline sequence in women: testosterone drops first, especially after a second delivery, then progesterone goes low, and estrogen is "the last one." He also tied low libido directly to the combination of high estrogen, low progesterone, and low testosterone, saying that's when women have "no desire for intimacy." He framed testosterone as the hormone behind energy, fat loss, collagen, and recovery. The caption frames all of this as a reframe for women who think relationship problems are causing low sex drive. That's actually a reasonable clinical instinct. The specific hormonal sequencing claims are where things get more complicated.

Does the science back this up?

Partially, but the confident sequencing is not well-supported by evidence. The claim that testosterone is universally the first hormone to decline in women after childbirth oversimplifies a genuinely complex picture. Postpartum hormonal shifts are dominated by the rapid fall of estrogen and progesterone after delivery, not testosterone. Studies like Davis et al. (2005, Journal of Clinical Endocrinology and Metabolism) confirmed that testosterone does play a role in female sexual function, but its decline pattern varies widely by age, reproductive stage, and individual physiology. The idea of a neat, predictable sequence, testosterone first, then progesterone, then estrogen, reflects clinical pattern recognition more than established endocrinology. That's not nothing, but it's not the same as peer-reviewed consensus. On the libido question, the evidence is stronger. Wierman et al. (2014, Journal of Clinical Endocrinology and Metabolism) reviewed the literature and found some evidence linking low testosterone to decreased sexual desire in women, though the effect size and causality remain debated.

What did they get wrong (or right)?

Let's give credit where it's due. The core message, that low libido in women often has a hormonal basis and isn't purely psychological or relational, is supported by research. Braunstein et al. (2005, NEJM) demonstrated that transdermal testosterone improved sexual function in surgically menopausal women. That's real. But the framing of testosterone as "the first hormone to go low" after a second delivery is stated as clinical fact when it's actually a clinical impression. Postpartum, prolactin surges and estrogen bottoms out. Testosterone in the postpartum period is complicated by lactation, sleep deprivation, and HPA axis stress, and it doesn't follow a clean decline rule. The claim that "when estrogen's high, progesterone's low and testosterone" drives no desire is also an oversimplification. Relative hormone ratios matter, but the research on libido involves dopaminergic pathways, relationship context, and mental health, not just three hormone levels. Reducing it to that formula is too tidy.

What should you actually know?

If you're experiencing low libido, fatigue, or other symptoms that feel hormonal, the honest answer is that hormones are worth checking, but no provider can tell you in advance which one will be low. Female hormonal physiology doesn't follow a universal script. A proper workup should include free and total testosterone, estradiol, progesterone (timed to cycle phase if premenopausal), FSH, LH, prolactin, and thyroid function. Interpreting those results requires clinical judgment, not a predetermined decline sequence. For women in perimenopause or menopause, the evidence for testosterone therapy improving sexual desire is reasonably solid, though the FDA has not approved any testosterone product specifically for women in the US. That's a real regulatory gap, not a conspiracy. Any provider offering hormone therapy should be working from your actual lab values, not a one-size-fits-all narrative about which hormone falls first. Symptoms matter, but so does the data.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr. Allen · TikTok creator

12.4K views on this video

Low libido? This is one of the first symptoms that comes up commonly in Dr.Allens practice. You don’t hate your husband! It’s your hormones #lowlibido #libido #drallen #menopause #menopausesupport

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about postpartum hormone changes?

Postpartum hormone changes are dominated by estrogen and progesterone withdrawal plus prolactin elevation, not a testosterone-first decline; no peer-reviewed consensus supports the sequence Dr. Allen describes.

What does the video say about low testosterone?

Low testosterone is associated with reduced sexual desire in some women, but the FDA has not approved any testosterone product specifically for female sexual dysfunction in the US as of 2024.

What does the video say about straw+10 (harlow et al., 2012, fertility?

STRAW+10 (Harlow et al., 2012, Fertility and Sterility) defines perimenopause through rising FSH and erratic estradiol, not a neat three-hormone stepwise decline.

What does the video say about a proper hormonal workup for low libido in women should?

A proper hormonal workup for low libido in women should include free and total testosterone, estradiol, progesterone (cycle-timed if premenopausal), FSH, LH, prolactin, and thyroid function, not a predetermined diagnosis.

What does the video say about braunstein et al. (2005, nejm) found?

Braunstein et al. (2005, NEJM) found that transdermal testosterone improved sexual function in surgically menopausal women, giving some legitimacy to testosterone's role, though this does not confirm Dr. Allen's specific decline sequence.

What does the video say about female sexual dysfunction?

Female sexual dysfunction is multifactorial; Davis and Worsley (2014, Journal of Sexual Medicine) noted that hormones, mental health, relationship quality, and medications all contribute and should be assessed together.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Dr. Allen, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.